Ullman Medical
Plant-based Psoriasis Therapy
Company Overview
Snapshot
Founded in January 2009, Ullman Medical operated with 1–10 employees. The company focused on developing a novel botanical extract for psoriasis treatment, which demonstrated positive human clinical data. In January 2018, Ullman Medical secured patents related to its medical innovations.
Business overview
Ullman Medical is a Health Tech and Life Sciences company specializing in Pharmaceuticals, particularly in Drugs Discovery & Development. The company developed a novel botanical extract for the topical treatment of psoriasis, supported by positive human clinical data. Beyond dermatology, pre-clinical evidence indicated potential applications in treating eye diseases, arthritis, and certain cancers due to its non-toxic, anti-angiogenesis properties. Ullman Medical aimed to commercialize this plant-based compound and establish a therapeutic platform for various immune-deficient diseases, addressing the need for safe and effective topical treatments for chronic skin conditions.
Strategic signal
In January 2018, Ullman Medical secured patents for its medical innovations, signaling a validation of its research and development efforts in the pharmaceutical space. This intellectual property protection is crucial for a company focused on novel botanical extracts, as it establishes a competitive advantage and provides a foundation for future commercialization and therapeutic platform development in areas like psoriasis treatment and other immune-deficient diseases.
Company Intelligence Q&A
- What is Ullman Medical's primary focus?
- Ullman Medical focuses on developing a novel botanical extract for the topical treatment of psoriasis, with potential applications for other immune-deficient diseases, eye diseases, arthritis, and certain cancers.
- What is the status of Ullman Medical?
- Ullman Medical is non-active and ceased to operate in March 2019.
- When was Ullman Medical founded?
- Ullman Medical was founded in January 2009.
- What significant intellectual property development did Ullman Medical achieve?
- In January 2018, Ullman Medical secured patents related to its medical innovations, specifically for its novel botanical extract.
- What markets did Ullman Medical target?
- Ullman Medical targeted the Israel geomarket with its plant-based psoriasis therapy.